Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 125 participants.
Also called NCT05217485
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 125 participants
- Registry
-
NCT05217485
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT05217485. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-03 (anticipated); primary completion 2023-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis
- Acronym
- CAMS-AF
- Condition
- Atrial Fibrillation
- Condition
- Sepsis
- Condition
- Infections
- Condition
- Cardiac Arrhythmia
- Intervention (Device)
- Zio 14-day cardiac patch
- Lead sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Collaborator
- University of Cambridge
Record details
- Record id
cardio:ct-nct05217485- Content hash
4623334d757a65d91585489a7e8405569114fd6856f8edd78f26f6ee360ffb89